The civic record
Read. Follow. Verify.New Jersey bill requires health insurers and Medicaid to cover Alzheimer's testing and treatments
Last action · May 4, 2026: Introduced in the Senate, Referred to Senate Commerce CommitteeSponsors: Gordon Johnson and 22 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Would Do
Senate Bill 4073 requires health insurance contracts, state health benefits programs, and the state Medicaid program to cover medically necessary diagnostic testing and FDA-approved treatments or medications that slow the progression of Alzheimer's disease and related disorders. The bill prohibits insurers from requiring for these treatments and sets an effective date on the 180th day following enactment.
Patients enrolled in New Jersey state-regulated health plans or Medicaid gain mandatory insurance coverage for Alzheimer's progression-slowers and diagnostic testing without facing protocols.
Who It Would Affect
Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.
Patients with Alzheimer's disease and related disorders
Patients gain guaranteed health insurance and Medicaid coverage for medically necessary diagnostic testing and FDA-approved progression-slowing medications without step therapy requirements.
Health insurance carriers
Insurers must update their policies, contracts, and health benefits plans to provide coverage for Alzheimer's diagnostic testing and progression-slowing treatments in accordance with FDA labels.
State Health Benefits Commission and School Employees’ Health Benefits Commission
The commissions must ensure that every contract they purchase provides coverage for medically necessary diagnostic testing and FDA-approved Alzheimer's treatments.
Medicaid program
The Medicaid program must provide coverage for Alzheimer's diagnostic testing and progression-slowing treatments, and the Department of Human Services must seek necessary federal waivers.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What types of insurance plans are affected by this bill?
Does the bill allow insurance companies to require step therapy for Alzheimer's treatments?
When will these insurance requirements take effect if passed?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
Currently in committee. The next step in the legislative lifecycle is Floor Vote.
Procedural history
1 action- May 4, 2026SenateIntroducedIntroduced in the Senate, Referred to Senate Commerce Committee
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Show 18 more sponsors
Connected Entities
Sources
njleg.state.nj.us
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy25Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools
